Zen (Pharmaceuticals and Biotechnology) Company Profile: Valuation & Investors

Zen (Pharmaceuticals and Biotechnology) Overview

Founded
2011

Status
Private

Employees
19

Latest Deal Type
Seed

Latest Deal Amount
$3M

Zen (Pharmaceuticals and Biotechnology) General Information

Description

Manufacturer of sports balms intended to provide pain relief. The company's products include formulations that remove any inflammation or muscle spasm and are free of harmful chemicals, dyes, and preservatives, enabling users to gain quick pain relief from injuries.

Contact Information

Website

www.zenpainreliever.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Primary Office

9061 West Sahara
Suite 105
Las Vegas, NV 89117
United States

+1 (855) 000-0000







Zen (Pharmaceuticals and Biotechnology) Timeline

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zen (Pharmaceuticals and Biotechnology) Valuation & Funding

Deal Type	Date	Amount	Raised to Date	Status	Stage
5. Seed Round	08-Feb-2022	$3M	00.000	Completed	Generating Revenue
4. Angel (individual)	07-Dec-2020			Cancelled	Generating Revenue
3. Seed Round	29-Jul-2019	00000	00.000	Completed	Generating Revenue
2. Seed Round	16-Mar-2017	$1.9M	$4.05M	Completed	Generating Revenue
1. Seed Round	19-Jan-2016	$2.15M	$2.15M	Completed	Generating Revenue